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A B S T R A C T
Mycobacterium ulcerans infection (Buruli ulcer) causes necrotizing lesions that may lead to scarring,
contractures, osteomyelitis, and even amputation. Despite decades of research, the reservoirs andmodes
of transmission for M. ulcerans remain obscure. A thorough evaluation of the potential risk factors
examined in comparative epidemiological studies may help to identify likely transmission routes. A
systematic search of the literature found that poor wound care, failure to wear protective clothing, and
living or working near water bodies were commonly identiﬁed risk factors. Socioeconomic status, BCG
vaccination, and direct water contact were not associated with signiﬁcantly increased or decreased risk
of infection. Additional comparative studies are required to clarify the potential roles of water contact
and insect bites in transmitting M. ulcerans to humans.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Mycobacterium ulcerans infection, alternately known as Buruli
ulcer, Bairnsdale ulcer, Daintree ulcer, Mossman ulcer, and Searls’
ulcer, causes necrotizing lesions that can lead to scarring and
contractures, and in some cases to osteomyelitis and amputation.
The lesions often appear on a limb, but may occur on any part of
the body.1–4 While the majority of cases are found in west and
central Africa, the geographic range is not limited to the tropics.
Cases have also been reported from Australia, South America,
Mexico, China, Japan, and several island nations in the Paciﬁc and
Indian Oceans, such as Papua New Guinea, Malaysia, Indonesia,
and Sri Lanka.2,5,6
M. ulcerans infection is a generally painless ulcerative disease
with a characteristic progression.2,3,7–12 After an incubation period
of up to three months or longer, initial infection presents as
erythema and induration at the infection site. This stage is followed
by the formation of a nodule, papule, or raised plaque on the skin
that slowly progresses through the dermis and into the subcuta-
neous tissue and often the fascia. The absence of pain means that a
person with the infection often delays seeking care until the ulcer
is at an advanced stage. At diagnosis, the characteristic presenta-
tion is a necrotic skin ulcer with edges that are undermined and
tunneled. In other words, the ulcer typically has overhanging
margins and is usually larger in diameter under the skin than at the* Corresponding author. Tel.: +1 703 993 9168; fax: +1 703 993 1908.
E-mail address: kjacobse@gmu.edu (K.H. Jacobsen).
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doi:10.1016/j.ijid.2009.11.013surface. Advanced infection may affect nerves, blood vessels, and
connective tissue. Subcutaneous fat is usually affected and
osteomyelitis can occur, especially when multiple lesions are
present, and may lead to contractures and to amputation.3,8,13–16
The subsequent disability may lead to limitations in work and
schooling.8,17–19 Scarring from the infection is also associated with
psychological distress20–22 and stigma.20,22–24
Anti-mycobacterial therapy may signiﬁcantly reduce the
amount of necrosis, especially when therapy is initiated soon
after the lesion appears and continues for several months.2
Commonly used drugs for treating this Gram-positive bacterial
infection include quinolones like ciproﬂoxacin, macrolides like
clarithromycin, aminoglycosides like streptomycin, and other anti-
mycobacterials such as rifampin.2,3,11,25 The use of a combination
of rifampin and an aminoglycoside is recommended.26,27 For larger
lesions, surgical excision is often required, andmay necessitate the
use of skin grafts.2,3,11,12 Negative pressure drains and heat therapy
may encourage post-surgical healing,3 but successful treatment
often requires lengthy hospital stays.4 Topical treatments with
chemicals such as hypochlorite, chlorhexidine, iodine derivatives,
nitrites, phenytoin powder, and clay may also promote healing but
have not yet been thoroughly tested.25
Despite decades of research, the mode of transmission of M.
ulcerans remains obscure. Several recently published review
articles have discussed potential reservoirs, vectors, and transmis-
sion mechanisms, but no articles have systematically examined
possible risk factors for infection. A thorough analysis of known
risk factors for the infection may help to identify likely
transmission routes and to eliminate unlikely pathways.ses. Published by Elsevier Ltd. All rights reserved.
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characteristics of the disease followed by an evaluation of the
risk factors analyzed in comparative studies of the disease. The
paper concludeswith an examination of theories of transmission in
light of the risk factor analysis, and highlights questions that need
to be addressed in future studies.
2. Methods
Articles were identiﬁed by searching several abstract databases
for both ‘Mycobacterium ulcerans’ and ‘Buruli ulcer’, and by
examining the reference lists of included papers for additional
relevant articles. This extensive search of the literature from all
years and languages yielded more than a dozen comparative
studies that allow for the direct identiﬁcation of risk factors,
because they compare individuals with and without the disease.
Most of the analysis in this paper is based on information extracted
from these comparative studies, which are summarized in Table 1.
While caution must be taken when comparing studies that were
conducted in different parts of the world, used different control
populations (as noted in the Table), and might have had slightly
different case deﬁnitions, comparing the ﬁndings of a diversity of
published reports is an essential step in clarifying what is known
and what is not known about the etiology of the disease.
In addition, the search identiﬁed well over 50 case series and
clinical trial reports in which all participants had M. ulcerans
infection, and more than 30 review articles and environmental
studies. Despite their usefulness in clarifying the natural history of
disease and evaluating the effectiveness of various treatment
protocols, case series and clinical trial reports are of limited
assistance in identifying risk factors, since they usually only report
on the number or proportion of cases that exhibit a particular
characteristic, and do not compare these counts or rates to the
general or unaffected population. However, several of these studies
that provide essential information about agent, host, and
environmental characteristics linked to M. ulcerans infection and
are also referenced in this paper.
3. Results
3.1. Demographics
Most case–control studiesmatched participants by age and sex,
so it is impossible for these matched studies to assess age and sex
differences between cases and controls. Of the comparative studies
that did not match on these characteristics, one found a higher rate
of M. ulcerans disease among children aged 5–14 years,28 while
others found no statistically signiﬁcant differences by ageTable 1
Comparative studies of risk factors for Mycobacterium ulcerans
Country Year Sample size Co
Australia 2005 658 (49 cases, 609 controls) Po
Benin 2002–2003 1039 (426 cases, 613 controls) Co
Benin 2002–2003 1497 (324 cases, 1173 controls) Ne
Benin 2000–2002 892 (15 cases, 877 controls) Co
Benin 1997–2003 3843 (2399 cases, 1444 controls) Ho
Cameroon 2006 326 (163 cases, 163 controls) Co
fa
Coˆte d’Ivoire 1991 412 (312 cases, 100 controls) Co
Ghana 2000 270 (121 cases, 149 controls) Ne
Ghana 2000 212 (106 cases, 106 controls) Ne
Ghana 1999 102 (51 cases, 51 controls) Ho
Ghana 1991 180 (90 cases, 90 controls) Ne
Ghana not listed 66 (33 cases, 33 controls) Ho
Uganda 1969–1972 Hundreds (47 cases) Po
pr
Uganda 1970–1971 144 (72 cases, 72 controls) Negroup.8,16 The sites of lesions may also vary with age. For example,
studies in West Africa have found that children tend to develop
lesions on the trunk, head, neck, and upper limbs, while adults tend
to develop lesions on the lower limbs.10,14,29,30
Although cross-sectional surveys and case series seem to
indicate that children and adolescents have higher rates of
infection by M. ulcerans than adults,4,10,13,29,31–41 only a few of
these studies based their observations on patient counts rather
than rates, so it is not clear if the higher numbers of cases in young
people is simply a reﬂection of a population structure that has a
relatively large proportion of children or if there truly is an
increased rate in children. For example, children aged 0–14 years
were responsible for half of the total number of cases of Buruli
ulcer in a case series from Benin, but the rate of infection was
considerably higher in adults over age 60 than it was in children.14
(Some other studies, mostly from Australia, have found a higher
number of infections in adults than children.42–45)
Similar challenges make it difﬁcult to identify potential
differences in the proportion of males and females affected by
age group, but the comparative studies that evaluated sex as a risk
factor consistently found no association between sex and M.
ulcerans infection.8,16,28,46–48 Although some age groups may have
an increased risk of infection in some areas, there do not appear to
be signiﬁcant differences in risk by sex.
3.2. Socioeconomic status
Only a few comparative studies evaluated socioeconomic risk
factors for M. ulcerans infection, and the results were mixed. One
study found increased risk among individuals from households
with low ownership rates,49 but another study found no
association between infection and household spending per
day.16 One study found an increased risk of infection associated
with participation in agricultural activities,28 but most found no
association.16,50,51 One study focusing on education found an
increased risk among those with only a primary education,16 but
another study found no association between education and
infection.22 No association was found between M. ulcerans
infection and other proxies for socioeconomic status, such as
household size,16 livestock ownership,47 or the construction
materials used to form the walls and ﬂoors of the house.16 Most
of the comparative studies were conducted in rural areas, which
suggests that rural residents have an increased risk of M. ulcerans
than urban residents. Proving that rural residence is a risk factor
will require studies that directly compare rates in areas with
different population densities, but recent landscape-based models
suggest that this will be true.52 It seems reasonable to assume that
individuals with lower socioeconomic status will have reducedmparison population Matching variables Reference
pulation-based controls Unmatched 46
mmunity controls Age, sex 53
ighbor controls Age, sex 49, 51
mmunity controls Unmatched 30
spital controls Unmatched 28
mmunity and
mily controls
Age, village, classroom
(for primary school children)
16
mmunity controls Unmatched 8
ighbor controls Age 47
ighbor controls Age 48
spital controls Age, sex, BCG 50
ighbor controls Age, sex 1
spital controls Age, sex 22
pulation-based
ospective cohort study
Unmatched 54
ighbor controls Age, sex 55
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severity of the ulcer and the risk of long-term disability as a result
of the infection, but there is no evidence that incidence rate is
strongly associated with socioeconomic status.
3.3. Health and hygiene
Although cases and controls in one study did not have
differential recall of penetrating injuries,47 wound care and
hygiene appear to be associated with risk of M. ulcerans infection.
Failure to immediately care for wounds by washing them with
soap and bandaging them has been associated with an increased
risk of infection.16,46,51 Using soap for washing is associated with a
decreased risk of infection.47,51 Washing clothes has also been
found to be protective.8,16 Other healthcare-related factors may
also be related toM. ulcerans infection. Proximity to a hospital has
been associated with a decreased risk of infection.28 No consistent
association has been found between most infections and co-
morbidities like diabetes and cancer,46 but HIV/AIDS may increase
the risk of infection.47,53 Household exposure does not appear to be
particularly risky, since several studies found no association
between having a family member with M. ulcerans infection and
developing an ulcer.47,50,51 While these studies do not prove that
poor wound care increases the incidence of M. ulcerans infection,
better wound management and earlier medical intervention, if
necessary, seem likely to reduce the severity of infection and
would be appropriate to include as part of a comprehensive
prevention and control strategy.
3.4. BCG vaccination
Although an early study of BCG and Buruli ulcer suggested that
BCG conferred protection against M. ulcerans infection,41 most
evaluations of BCG have not found the vaccine to be effective in
conferring protection against incident infection.1,16,28,46,47,49 BCG
may confer some protection against osteomyelitis,37,38 although
other studies have found only a weak or no association between
BCG and osteomyelitis.49 BCG may also be associated with
improved healing of ulcers following surgery40 and a reduction
in recurrence of disease following surgery.35 However, the possible
association of BCG with improved clinical outcomes does not
indicate that BCG protects against incident cases.
3.5. Insect bites
The results from studies that evaluated the potential associa-
tion between insect bites and M. ulcerans infection were
inconclusive. In one study, cases were more likely than controls
to recall having mosquito bites on the lower legs.46 In another
study, casesweremore likely than controls to recall being bitten by
insects while wading in water or mud.16 These cases, however,
were also more likely than controls to believe that bites cause
Buruli ulcer,16 and that may have contributed to biased recall of
past bites. A third study found no differential recall of insect bites
near water.47 The use of mosquito repellants and barriers was also
somewhat inconsistent. Two studies found a decreased risk of
infection with mosquito net use16,51 and a third found that use of
insect repellant was associated with decreased risk of infection.46
However, another study found no association between bed-net use
and infection,47 and two studies found that the use of mosquito
coils was not associated with a decreased risk of infection.16,47
These studies do not provide strong evidence for or against an
insect vector being involved in the transmission process.
Wearing protective clothing, however, does seem to be
associated with a reduced risk of infection. Many studies identiﬁed
not wearing long-legged trousers as a risk factor for M. ulceransinfection,8,16,46,47 and some studies also found an increased risk
associated with not wearing long-sleeved shirts.16,47 The protec-
tive effect of covering clothing was noted to be especially strong
among farmers.16,47 Gardening gloves46 and shoes,8,47 however,
were not found to be protective, perhaps because hands and feet
are rare sites for ulcers, so the beneﬁts of protecting these areas
provides minimal beneﬁt compared to more likely sites of
ulceration. Protective clothing may prevent not only insect bites,
but also scratches and other cuts and lacerations that could provide
a portal of entry to the agent.
3.6. Water contact
Several studies have noted that cases were more likely to drink
water fromunprotected stagnantwaters such as ponds and swamp
waters than from protected water sources such as wells or free-
ﬂowing water sources such as rivers,28,51,54 but one found an
increased risk with use of river water50 and other studies have
found no differences in case status by drinking water
source.1,16,47,55 Infection with M. ulcerans has not been found to
be associated with the source of water used for cooking,50
bathing,50,55 or washing.47,50 Some studies have found an
increased risk of infection associated with wading in water,16,47
but recreational and occupational activities such as gardening,46,55
hunting,47 ﬁshing,8,16,47 and swimming8,50 have not usually been
linked with infection. Several studies – though not all1 – have
found an association between proximity of the home or farm site to
a water source and increased risk of infection.8,16,46,47,51 Living
near non-water features such as a forest or plantation16 or walking
through areas like bush and forest47 have not been associated with
infection. In other words, living near water appears to be risky, but
direct contact with water does not. This may suggest that water,
mud, or insects that live on or near water are related to
transmission, but does not clarify their speciﬁc roles.
4. Discussion
4.1. Reservoir
The primary risk factor for M. ulcerans infection seems to be
living in proximity to a body of water, even if contact with water is
not consistently shown to increase the risk of infection. Artiﬁcial
water bodies, such as lakes created from the damming of streams,
modiﬁcation of wetlands in resort areas, ﬂooding, and agricultural
irrigation systems, have been reported as possible factors
contributing to outbreaks,56,57 and M. ulcerans has been detected
in water from outbreak zones.58,59 The agent has been detected in
water from both endemic and non-endemic sites,60 so the presence
of M. ulcerans in a particular region may not indicate whether
humans in that area are at risk. Animals have also been theorized to
serve as reservoirs for infection. For example, some ﬁsh, especially
those that feed on insects, and some mollusks have tested positive
forM. ulcerans,61,62 andmay serve as reservoirs of infection, but are
unlikely to be directly involved in transmission to humans.
4.2. Portal of entry
There are two primary theories about the portal of entry forM.
ulcerans into the human body.56 The more popular theory is that
trauma to the skin provides a site for introduction of M. ulcerans
into the body.63 Existing abrasions or lacerations could serve as the
portal, or a wound could be created by the bites of potential insect
or other vectors or by plants. Although failure to immediatelywash
wounds was found to be a risk factor in several of the studies
examined in the previous section, most studies did not ask
individuals with Buruli ulcer about recent skin conditions at or
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likely than controls to remember wounds, may be a limitation,
future studies would beneﬁt from more closely exploring this
aspect of medical history. The secondmain theory is that the agent
may be able to enter the respiratory system if it is aerosolized from
water and inhaled or ingested, or that aerosols from ponds and
swamps may contaminate the skin surface. This has not been
widely tested and is based primarily on one investigation of an
outbreak in Australia.64
4.3. Mode of transmission
Several hypotheses about the mode of transmission have been
proposed.2,5,25,57 One possibility is that insects transmit the
bacterium. Public health research from Australia shows that the
incidence of M. ulcerans strongly correlates with the incidence of
other vector-borne infections.65 The proposed mechanical vectors
are biting aquatic bugs from the order Hemiptera, including insects
from the families Naucoridae and Belostomatidae, that feed
primarily on other water bugs, snails, and small ﬁsh, but
occasionally bite humans.66 These insects are usually found near
the roots of several types of aquatic plants, but they also ﬂy
between swamps and ponds, so they could be involved in infecting
persons who have not had water contact.66 However, although the
bacterium has been detected in these insects,60,62,66,67 laboratory
studies have not speciﬁcally shown that the insects are capable of
transmitting the agent to humans, and recent ﬁeld research has not
supported the hypothesis that these insects are primary vectors of
M. ulcerans.68 A second possibility is that direct transmission
occurs when a susceptible body part comes into contact with
contaminated water, soil, aquatic plants, or the bioﬁlm on aquatic
plants. However, although laboratory-based studies have demon-
strated that bioﬁlm-attached bacteria can form on organicmaterial
from aquatic plants,69 studies of the roots, stems, and leaves of
aquatic plants collected from endemic areas have not resulted in
positive cultures.66 The evaluation of risk factors presented in this
paper does not rule out any of these modes of transmission, nor
does it point to one most likely mechanism.
5. Conclusions
The goal of this paper was to identify common risk factors forM.
ulceransdisease and touse this information to examine likelymodes
of transmission forM. ulcerans. There do not appear to be signiﬁcant
differences in risk of disease by sex, participation in agricultural
activities, BCG vaccination status, or household exposure to M.
ulcerans. Potential differences in risk by age vary signiﬁcantly by
world region. There are mixed results for socioeconomic status,
drinking water source, and the use of insect repellents and barriers,
although proximity to a body of water and failure to wear covering
clothing are consistently associated with an increased risk of M.
ulcerans disease. Thus, an examination of currently identiﬁed risk
factorsandunassociatedfactorsdoesnotprovidestrongevidence for
or against vector-borne transmission or transmission via direct
water contact. Further research on environmental reservoirs and
possible hosts or vectors is required to clarify possible modes of
transmission, and additional comparative studies are needed to
reﬁnethespeciﬁcexposuresthatmayfacilitate infectionanddisease.
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